{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/glandular-fever-infectious-mononucleosis/management/management/","result":{"pageContext":{"chapter":{"id":"b30178b8-7559-5763-9b53-da80a5c066e6","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field 8becc1cc-c0a2-4017-bd76-8dddead88996 --><h2>Scenario: Management of glandular fever</h2><!-- end field 8becc1cc-c0a2-4017-bd76-8dddead88996 -->","summary":"Covers the management of acute glandular fever.","htmlStringContent":"<!-- begin item 48148d16-b4ae-42ab-91e6-f7e7f0a59b36 --><!-- begin field 27284f57-ed42-4daf-a02f-acbc01574482 --><p>From age 1 month onwards.</p><!-- end field 27284f57-ed42-4daf-a02f-acbc01574482 --><!-- end item 48148d16-b4ae-42ab-91e6-f7e7f0a59b36 -->","topic":{"id":"79787412-82dc-54ee-8f4d-82bb69926abd","topicId":"c9504b30-5339-4b0e-ae98-8637960b13dd","topicName":"Glandular fever (infectious mononucleosis)","slug":"glandular-fever-infectious-mononucleosis","lastRevised":"Last revised in March 2020","chapters":[{"id":"fe86b21c-212e-588d-8fa4-c3ba5660eac1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"5f9a86f5-ef8f-544d-913a-a590a53535c1","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0a089fd0-524b-5897-8e6a-ddf549b68ab1","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"4bb31918-f826-5ad9-94c9-277390a6c0a6","slug":"changes","fullItemName":"Changes"},{"id":"1b1796e9-9f11-5086-8044-c244b38cab9f","slug":"update","fullItemName":"Update"}]},{"id":"e8f82c54-74bc-5c96-8ae4-915ef47cdc57","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"e297f8dd-9da6-5f6e-994d-22be9b9c25ce","slug":"goals","fullItemName":"Goals"},{"id":"3046ea37-29e3-531b-988d-b845fd950135","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4e842d69-8714-5155-a670-debee1452013","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6002b762-9bc1-544a-8bd4-9a17721ee873","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"91fe23ad-4802-56ea-b009-10c57fe2af06","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ff9cc4d0-961b-5fb9-9e50-cd71cb09ddb1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"41104316-b37f-5c24-a33f-610e21b30c2d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a208aaf3-91cd-5db4-a414-d800668d35fc","slug":"definition","fullItemName":"Definition"},{"id":"b7c5aaaf-3ffa-5941-bfcf-9eb30289d4eb","slug":"transmission","fullItemName":"Transmission"},{"id":"364f7cae-6906-5430-bfa6-9ad3296bd449","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a7fec36d-ff3b-5ead-aeee-30729eae51ae","slug":"complications","fullItemName":"Complications"},{"id":"e1e96b16-d495-5d31-a3dd-0b7f997675c9","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"35cc3b18-c5a7-5454-945f-cc1a5cffedbe","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"cfa76822-5481-564e-aa8b-2ceb86498f56","slug":"when-to-suspect-glandular-fever","fullItemName":"When to suspect glandular fever"},{"id":"8a953b4a-1996-57f6-8218-930f5cd54cfd","slug":"investigations","fullItemName":"Investigations"},{"id":"8eac8de5-26bd-5922-9d20-a425bce60c31","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"051ad3a0-73e9-53c8-890d-b540a5d79c9a","fullItemName":"Management","slug":"management","subChapters":[{"id":"b30178b8-7559-5763-9b53-da80a5c066e6","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"93f8bf53-780c-5f2a-b227-a71262e777ba","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"05273e44-731a-5c3f-8f4b-d3b9e0cb29d5","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"03c591a1-efa5-5fc3-ae2c-d8673f74824b","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"86912120-67f4-52e6-b125-bce8acabc24c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7018815e-d09a-5a62-8337-00be6807f631","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e8044e6c-e133-5cf3-a6a0-abef3123bc04","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"224ddc8a-471e-5b1b-8c3e-6b1e744b6d80","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"74aec8a3-1f73-550b-9f3f-2020afd164b8","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"051ad3a0-73e9-53c8-890d-b540a5d79c9a","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"5c016066-21a3-55bd-9f47-8e5bbbc9a057","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 0f83d9bd-4760-4e3d-93c3-b6245a601621 --><h3>How should I manage a person with suspected or confirmed glandular fever?</h3><!-- end field 0f83d9bd-4760-4e3d-93c3-b6245a601621 -->","summary":null,"htmlStringContent":"<!-- begin item ea58551d-0847-422a-969f-c69e46da59dd --><!-- begin field e492879f-cc14-46fe-a50d-fe6849cb0850 --><ul><li><strong>Arrange hospital admission if the person has:</strong><ul><li>Stridor.</li><li>Dehydration or difficulty swallowing fluids.</li><li>A suspected potentially serious <a class=\"topic-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/background-information/complications/\">complication</a> of glandular fever, such as splenic rupture.</li></ul></li><li><strong>If hospital admission is not indicated:</strong><ul><li>Advise on the use of paracetamol or ibuprofen to relieve pain and fever symptoms. <ul><li>See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a> for prescribing information on these analgesics.</li></ul></li><li>Explain the expected course of the illness. Advise that:<ul><li>Symptoms usually last for 2–4 weeks.</li><li>Tiredness is common and is often the last symptom to resolve. </li></ul></li><li>Advise the person: <ul><li>That exclusion from work or school is not necessary.</li><li>To return to normal activities as soon as possible. If they are tired, they should tailor their activities to what they can manage comfortably. Bed rest is not normally needed.</li><li>To limit spread of the disease by avoiding kissing and sharing eating or drinking utensils, and to thoroughly clean all items that may have been contaminated by saliva.</li><li>To avoid heavy lifting and contact or collision sports for the first month of the illness (to reduce the risk of splenic rupture).</li></ul></li><li>Provide written information on glandular fever.<ul><li>Patient information is available on the NHS website (<a data-hyperlink-id=\"568195a6-0013-4fc9-907e-ab71014dd6f5\" href=\"https://www.nhs.uk/conditions/glandular-fever/\" rel=\"noreferrer noopener\" target=\"_blank\">www.nhs.uk</a>). </li></ul></li><li>Advise the person to seek urgent medical advice if they:<ul><li>Develop stridor or respiratory difficulty.</li><li>Have difficulty swallowing fluids or have signs of dehydration, such as reduced urine output.</li><li>Become systemically very unwell.</li><li>Develop abdominal pain (may indicate splenic rupture).</li></ul></li></ul></li><li><strong>If a person has ongoing fatigue, </strong>see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/tiredness-fatigue-in-adults/\">Tiredness/fatigue in adults</a> for management information.</li></ul><!-- end field e492879f-cc14-46fe-a50d-fe6849cb0850 --><!-- end item ea58551d-0847-422a-969f-c69e46da59dd -->","subChapters":[{"id":"46de0eb8-2307-5dd8-8a13-9c8c59191441","slug":"basis-for-recommendation-602","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 5ae31862-bfad-4da6-ae62-daf0405d7828 --><h4>Basis for recommendation</h4><!-- end field 5ae31862-bfad-4da6-ae62-daf0405d7828 -->","summary":null,"htmlStringContent":"<!-- begin item 602caeb2-c23a-4d0b-8bec-87ec3d508c8f --><!-- begin field da2ffb30-24be-45ea-8a81-26d116b1f7e7 --><h5>Hospital admission</h5><ul><li>These recommendations are based on expert opinion in the Scottish Intercollegiate Guidelines Network (SIGN) guideline <em>Management of sore throat and indications for tonsillectomy </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">SIGN, 2010</a>] and a textbook on the Epstein-Barr virus (EBV) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">Johannsen, 2009</a>].</li></ul><h5>Symptomatic relief with paracetamol or ibuprofen</h5><ul><li>This recommendation is based on expert opinion in the Centers for Disease Control and Prevention (CDC) guidance on <em>Epstein-Barr Virus (EBV) and infectious mononucleosis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">CDC, 2018</a>] and in review articles<em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">Lennon, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">BMJ, 2018</a>].</li></ul><h5>Lifestyle advice</h5><ul><li>The recommendation that exclusion from work or school is not necessary is based on the Public Health England (PHE) document <em>Guidance. Health protection in schools and other childcare facilities. Chapter 9: managing specific infectious diseases. Glandular fever </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">PHE, 2019</a>].</li><li>The recommendations on activity levels are based on limited evidence from a small randomized controlled trial (RCT) of 69 cases of confirmed glandular fever, which showed that brief intervention encouraging graded physical activity may help to prevent the development of chronic fatigue. A fatigue questionnaire was completed at 6 months, which demonstrated there were fewer fatigue cases in the group that received brief intervention [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">Candy, 2004</a>].</li><li>The recommendation to limit the spread of disease by avoiding kissing and sharing eating or drinking utensils is based on expert opinion in the CDC guidance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">CDC, 2018</a>].</li><li>The recommendation on when to resume sporting activities/heavy lifting is based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">Balfour, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">Womack, 2015</a>] and in a textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">Johannsen, 2009</a>].</li></ul><h5>When to seek urgent medical advice</h5><ul><li>The recommendations on seeking urgent medical advice if there are breathing or swallowing difficulties are extrapolated from the SIGN guideline<em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">SIGN, 2010</a>].</li><li>The recommendations on seeking urgent medical advice if the person becomes systemically very unwell is pragmatic, based on what CKS considers to be good clinical practice.</li><li>The recommendation on seeking urgent medical advice if the person develops acute abdominal pain is based on expert opinion in a textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">Johannsen, 2009</a>].</li></ul><h5>Treatments not recommended in primary care</h5><ul><li><strong>Antiviral treatment</strong><ul><li>Antiviral drugs have been used to treat glandular fever, but the use of antivirals for this indication is controversial. They may be effective by preventing viral replication that helps to keep the virus inactive. However, there are no guidelines for the use of antivirals in glandular fever [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">De Paor, 2016</a>].</li><li>A Cochrane syetematic review (search date: April 2016) assessed the effects of antiviral treatment (acyclovir, valomaciclovir, and valacyclovir) for infectious mononucleosis and concluded that further research in this area is warranted [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">De Paor, 2016</a>].<ul><li>Although 2 of the 12 outcomes had results that favoured treatment over control, the quality of the evidence of these results were very low. The authors of the systematic review highlighted that in addition to the lack of evidence of effectiveness for antiviral treatments, the potential adverse effects, possible associated costs, and the risk of antiviral resistance should also be considered. </li></ul></li></ul></li><li><strong>Corticosteroid treatment</strong><ul><li>Cortisosteroids have been used for their anti‐inflammatory effects, but there are no universal criteria for their use [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">Rezk, 2015</a>].</li><li>A Cochrane syetematic review (search date: August 2015) assessed the efficacy and safety of corticosteroid treatment compared with placebo, usual care, or different drug therapies for symptom control in infectious mononucleosis. There was insufficient evidence for the efficacy of corticosteroid treatment for symptom control in people with otherwise uncomplicated glandular fever [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/references/\">Rezk, 2015</a>].</li></ul></li></ul><!-- end field da2ffb30-24be-45ea-8a81-26d116b1f7e7 --><!-- end item 602caeb2-c23a-4d0b-8bec-87ec3d508c8f -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}